Concepedia

Evelyn Worthington

EW

4

Publications

216

Citations

4

H-Index

1965

Active since

Affiliations

Novartis (Switzerland)(Current)

University Hospital Münster

EVERSANA (Canada)

Evelyn Worthington is an author at Novartis (Switzerland) specializing in medicine, omics, and rheumatology.

ORCID

Top concepts

Publications per year

1965–2022

4

Publications

4

Efficacy classification of modern therapies in multiple sclerosis

Imtiaz A. Samjoo, Evelyn Worthington, Christopher Drudge et al. · Journal of Comparative Effectiveness Research · 2021 · 112 citations · Full text

Comparison of ofatumumab and other disease-modifying therapies for relapsing multiple sclerosis: a network meta-analysis

Imtiaz A. Samjoo, Evelyn Worthington, Christopher Drudge et al. · Journal of Comparative Effectiveness Research · 2020 · 69 citations · Full text

The International Biological Programme

Evelyn Worthington · Nature · 1965 · 19 citations

, , +6

Simulated treatment comparison of efficacy outcomes for ofatumumab in ASCLEPIOS I/II versus ocrelizumab in OPERA I/II for the treatment of patients with relapsing multiple sclerosis

Imtiaz A. Samjoo, Luisa Klotz, Gavin Giovannoni et al. · Multiple Sclerosis and Related Disorders · 2022 · 16 citations

, , +6

Rows per page

1–4 of 4